Home / Veröffentlichungen / On the Pulse

On the Pulse

Willkommen bei „On the Pulse“ der Global Life Sciences & Healthcare Sector Group

Die Video-/Podcast-Reihe „On the Pulse“ führt Anwältinnen und Anwälte von CMS mit Expertinnen und Experten zusammen, um über Schlüsselthemen der Branche zu diskutieren, die Einfluss auf den Life Sciences & Healthcare Sektor haben, innovativ sind und diesen beeinflussen. Die Reihe wird von Nick Beckett moderiert, dem Global Co-Head der CMS Life Sciences & Healthcare Sector Group.

Sie können die CMS-Videos „On the Pulse“ hier und die Podcasts hier abonnieren, herunterladen und ansehen bzw. anhören.

 


Video

New! Episode #5 - Product Liability & Medical Malpractice

Nick Beckett talks with Alaina Wadsworth (CMS UK), David Bridge (CMS UK) and Laura Opilio (CMS Italy) on product liability and medical malpractice.

In this episode, we discuss:

  • international perspectives on product liability risk
  • the liability of Health Care Professionals (HCPs) “playing out of position” during COVID-19
  • the risks for non-Life Sciences manufacturers entering the Life Sciences space
  • the “search for a scape goat” – an easy hunting expedition?
  • a double track system in Italy and comparative perspectives
  • practical advice to companies to minimise risk
  • off-label use and relevant considerations

Episode #4 – Digital Health – Part 2

In this episode (Part 2), we discuss:

  • an increasing demand for digital health and increase in tele-consultations and use of chatbots
  • the digitalisation of healthcare records
  • the approach of Big Tech and their provision of advanced technical solutions
  • data privacy requirements regarding the use of immense data reserves in the provision of digital health services
  • the need to incorporate human insight and oversight into AI system processes

Episode #3 - Digital Health – Part 1

Nick Beckett discusses digital health with Rob Flaws (CMS Dubai), Niall McAlister (CMS UK) and Roland Wiring (CMS Germany).

In this episode (Part 1), we discuss:

  • the need for collaborations and to deal with a potential clash of cultures in bringing the “digital” and “health” sides of the industry together
  • the use of AI in track-and-trace and the search for a vaccine for COVID-19
  • the lack of clarity of the definition of AI
  • whether the EC White Paper sufficiently provides a comprehensive proposal for regulation of AI, and whether new legislation is required
  • where liability rests in respect of software

Episode #2 - Advertising of medicines and medical devices

Nick Beckett discusses with Dora Petranyi (CMS Hungary), Jens Wagner (CMS Germany) and Gabriela Staber (CMS Austria) the advertising of medicines and medical devices providing practical insights and an overview of the applicable laws.

In the episode, we consider:

  • the complicated and fast changing area of regulation of advertisements with different rules in different jurisdictions
  • how to verify that scientific evidence is sufficient to substantiate claims
  • the use of advertising in social media and other promotional campaigns
  • the approach of the authorities to new entrants to the market including in times of crisis
  • risks associated with competitors or consumer protection organisations filing claims
  • the potential impact of MDR on advertising of medical devices

Episode #1 – A legal roadmap for Cannabis

Nick Beckett discusses with Shuna Mason (CMS UK), Ellen Gielen (CMS Netherlands), Laura Opilio (CMS Italy) and how the medicinal cannabis industry is developing across Europe, the challenges it faces and what the future might hold. In particular, we discuss in this episode:

  • potentially the largest cannabis market on the planet;
  • how Moore’s law seems to apply to the legal opening up by authorities in Europe;
  • why there is yet to be significant use in practice;
  • what studies are needed to provide the hard scientific evidence healthcare professionals and authorities need to be comfortable with the efficacy and safety of medicinal cannabis;
  • whether recreational use in coffee shops may be diverted for medical use;
  • whether food supplements, cosmetics, drinks or even cigarettes could be an alternative means for patients to receive cannabis for medical purposes.

Podcast

New! Episode #5 - Product Liability & Medical Malpractice

Episode #4 – Digital Health – Part 2

Episode #3 - Digital Health – Part 1

Episode #2 - Advertising of medicines and medical devices

Episode #1 – A legal roadmap for Cannabis